According to Renub Research, report title “Global Microcarrier Market Report By Product Type (Consumables ((Microcarrier Beads, Media & Reagents)), Equipment), Application (Cell Therapy, Vaccine Manufacturing, Others) End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, Academic & Research Institutes), Countries and Company Analysis 2024-2032” The global microcarrier market is anticipated to grow, from US$ 1.89 Billion in 2023 to US$ 4.07 Billion by 2032.
Globally, in bioreactors, a microcarrier is a support matrix that permits adherent cells to grow. Microcarriers are commonly utilized to generate protein-producing or virus-producing adherent cell populations in the large-scale commercial manufacturing of biologics (proteins) and vaccinations. Microcarrier-based cell culture has recently received a lot of attention from scientists and engineers worldwide. Furthermore, as a vital source of cell therapy and tissue engineering, microcarrier technology has advantages for creating large numbers of functional cells while keeping their phenotypes. Tissue engineering has a promising future with enhanced microcarrier materials, particularly completely natural-material microcarriers.
Global Microcarrier Market will grow with a CAGR of 8.90 % during 2024-2032:
The growing occurrence of cancer cases is propelling the Microcarrier Market forward. In addition, the market’s growth would be fueled by the rising demand for cell-based vaccines over the forecast period. Cell culture is becoming a more important aspect of vaccine production in the pharmaceutical business. Previously, vaccinations were made by cultivating and extracting viruses in chicken eggs, which took a long period. Due to its shorter lead time and capacity to create vaccines in more significant numbers as needed, cell-based vaccine production has emerged as a considerably more efficient technology in this regard.
Furthermore, governments worldwide are boosting their spending on various sorts of healthcare research, and corporations are being encouraged to expand their research and development operations to take advantage of new cell therapy technology, which will aid in driving the microcarrier market.
Covid-19 Effect on the Worldwide Microcarrier Industry:
Following the World Health Organization’s (WHO) declaration of Covid-19 as a pandemic, a combination of big pharmaceutical corporations and small start-ups rushed to create treatments and vaccinations. Consequently, companies increased their research and development efforts to create vaccinations and treatments to combat the virus. Furthermore, the availability of financing and the demand for cell culture supplies, particularly microcarrier products, are likely to expand as research scales up. This will provide a notable boost to the worldwide microcarrier business.
: By Product Type: Equipment holds the majority share
The global microcarrier market is segmented into consumables and equipment based on product. The equipment segment holds the majority share. Moreover, the consumables category is predicted to acquire market share by competing with the market, and this sequence is expected to continue throughout the forecast period. Based on our analysis, the growth of this market is due to the increasing use of microcarrier beads, media, and reagents for a variety of applications, including cell culture processes.
Biopharmaceutical Production Holds the Lion’s Share:
By application, we have analyzed biopharmaceutical production, cell and gene therapy, tissue engineering, and regenerative medicine. The growing commercial expansion of major pharmaceutical businesses and increased demand for monoclonal antibodies can be linked to the biopharmaceutical production segment’s considerable stake. Besides, the current situation has changed as a result of technological improvements, and the importance of microcarriers in cell treatment has grown due to which cell and therapy segment will hike in the forecast period.
By end-user: Pharmaceutical and Biotechnology Companies Holds more than HALF of the Share:
As per our analysis, Pharmaceutical and Biotechnology companies hold the majority share by end-users of microcarriers. In the forecast period, research institutes will increasingly use microcarriers to test and produce a wide range of medications and vaccines and assist patients in combating terminal diseases. Researchers sometimes want a larger surface area and a larger cell population to conduct a deeper analysis while creating cell treatments. Microcarriers are frequently utilized in this situation because they have a more significant surface area and can assist enlarge the cell population.
North America will continue to dominate the Market over the Forecast Period:
According to our research, the North American region holds the highest proportion of the microcarrier market. The rising field of gene and cell therapy research and the organizations that support it are the main drivers of its expansion. One of the primary reasons driving the microcarrier market in this region is the high and rapid growth of the biologics and biosimilars industry in the United States.
The American Society of Gene and Cell Therapy, for example, is responsible for supporting the research and is pressuring biopharmaceutical and biotech corporations to enhance their R&D. Furthermore, the biologics and biosimilar industries in the United States are seeing rapid and robust growth driving forces behind the microcarrier market in North America.
Key Players Analysis:
We have studied Thermo Fisher Scientific, Merck KGaA, Eppendorf AG, Sartorius AG, Danaher Corporation, Lonza Group, Getinge AB Series B, GE Healthcare as the key players in Global Microcarrier Market. Furthermore, we have analyzed the business overview, sales analysis, and recent development of the companies. These companies prioritize various stages of organic evolution, including brand releases, patents, product approvals, and research and development efforts. Acquisitions, alliances, and agreements are all considered inorganic growth tactics in this industry.
Releted Report :
Market Summary:
Product type: We have studied Consumables and equipment as product type of microcarrier market.
Application: In our report, we have covered Biopharmaceutical Production, Cell and Gene Therapy, and Tissue Engineering and Regenerative Medicine as applications of the microcarrier market.
End-User: We have studied Pharmaceutical and Biotechnology Companies, Research Institutes, and CROs as end-users of the microcarrier market.
Region: We have studied the regional market of North America, Europe, Asia-Pacific, and Rest of World in the Global Microcarrier Market.
About the Company:
Renub Research is a Market Research and Consulting Company. We have more than 14 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.
Contact Us:
Renub Research
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Email: info@renub.com
LinkedIn: https://in.linkedin.com/company/renub-research
Web: www.renub.com
Thank You
